Related studies have found that HAS2-AS1 is abnormally expressed in a variety of cancers, such as epithelial ovarian cancer [9], breast cancer [10], non-small cell lung cancer [11] and oral squamous cell cancer [12], and induces the development of cancers. Here, HAS2 is linked to cancer.